Drug Delivery Infusion System Market Accelerates with Next-Gen & Wireless Trends, Projected to Reach US$ 22.62 Billion by 2033 | Medtronic, Eitan Medical, B.Braun SE, BD, Baxter, Terumo Corporation\n\nThe global drug delivery infusion system market was valued at US$ 12.80 Billion in 2023. The market size reached US$ 13.55 Billion in 2024 and is expected to reach US$ 22.62 Billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033.\n\nAs per DataM intelligence research report Market growth opportunities(2025-2031): Drug Delivery Infusion System market opportunities in the US and Japan arise from increasing demand for highly accurate, intelligent, and integrated infusion pumps suited for critical care, oncology, and MRI-compatible applications. Drug Delivery Infusion Systems with connected safety software, enterprise-level interoperability, and real-time dose monitoring support workflow efficiency and clinician adoption. Drug Delivery Infusion Systems tailored to oncology, including intra‐arterial devices like RenovoCath, align with rising precision therapy needs. Drug Delivery Infusion Systems that are non-magnetic and MRI-safe open new diagnostic use cases and drive hospital purchasing. Drug Delivery Infusion Systems with self-updating software and modular platforms facilitate hospital standardization and reduce training barriers. In Japan, regulatory approvals and aging populations accelerate demand for infusion systems with safety and convenience benefits. In both markets, expansion into outpatient, home infusion, and telehealth-linked usage broadens device relevance and supports long-term growth.\n\nDrug Delivery Infusion System Market: Recent Industry Developments\n✅In May 2025, Iradimed Corporation (US) received FDA 510(k) clearance for the MRidium® 3870, an MRI-compatible infusion pump featuring a non magnetic ultrasonic motor and touchscreen interface for use in MRI environments\n✅In April 2025, ICU Medical (US) received FDA 510(k) clearance for its Plum SoloTM and updated Plum DuoTM precision IV pumps, along with the LifeShieldTM infusion safety software, marking the launch of its new IV Performance Platform\n✅In early 2025, RenovoRx (US) expanded manufacturing of its FDA cleared RenovoCath® intra arterial drug delivery device, preparing for commercial launch in oncology applications in 2025\n\nDrug Delivery Infusion System Market: Technological Advancements\n➠In the US, Plum SoloTM and DuoTM pumps deliver ±3 % precision using cassette based mechanisms, with full-color touchscreens and integrated LifeShield safety software to minimize dosing variability across clinical environments\n➠In the US, MRidium® 3870 offers fully MRI-compatible infusion via a non magnetic ultrasonic pump motor and touchscreen UI, enabling fluid and drug delivery safely during imaging procedures\n➠In the US, RenovoCath® supports intra arterial micro perfusion delivery of chemotherapy near tumors under FDA clearance, enabling targeted infusion with reduced systemic exposure in oncology settings\n\nStrategic Players Driving the Drug Delivery Infusion System Market Forward: Medtronic, Eitan Medical, B.Braun SE, BD, Baxter, Terumo Corporation, Insulet Corporation, Fresenius Kabi AG, Arcomed, and ICU Medical, Inc., among others.\n\nSegment Covered in the Drug Delivery Infusion System Market:\n➥By Product Type: Volumetric Infusion Pumps, Syringe Infusion Systems, Ambulatory Infusion Systems, Implantable Infusion Systems, Insulin Infusion Pumps, Enteral Infusion Systems, Large Volume Infusion Systems, Patient Controlled Analgesia (PCA), Elastomeric Infusion Pumps\n➥By Application: Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Haematology, Paediatrics, Others\n➥By End User: Hospital, Specialty Clinics, Ambulatory Surgery Centers, Homecare Settings\n\nRegional Analysis for Drug Delivery Infusion System Market: The Drug Delivery Infusion System market is growing due to rising demand for targeted therapies, chronic disease management, and advanced medication delivery. North America, particularly the U.S., leads with high adoption in oncology, pain management, and diabetes care, supported by strong healthcare infrastructure. Europe, including Germany, France, and the U.K., shows steady growth driven by an aging population and technological advancements. Asia-Pacific, especially China, Japan, and India, is witnessing rapid expansion due to increasing healthcare spending and chronic disease prevalence. South America is gradually incorporating infusion systems in hospitals and specialty clinics. The Middle East & Africa are emerging markets with growth driven by healthcare modernization and increased access to treatment.

Drug Delivery Infusion System Market Accelerates with Next-Gen & Wireless Trends, Projected to...

The global drug delivery infusion system market is projected to reach US$22.62 billion by 2033, growing at a 6.8% CAGR. Key drivers include advancements in MRI-compatible pumps, precision therapy solutions, and expanded use in oncology, homecare, and telehealth. Major players like Medtronic, Eitan Medical, and ICU Medical have received FDA clearances for innovative devices, while regions like Japan and the U.S. lead in adoption due to aging populations and healthcare infrastructure.